TD139 is an inhibitor of the galectin-3 carbohydrate binding domain with Kd of 14 nM and shows therapeutic efficacy against idiopathic pulmonary fibrosis (IPF).

OTX008 is a calixarene-based compound and selective galectin-1 (Gal-1) inhibitor with potential anti-angiogenic and antineoplastic activities.

G3-C12 is a specific galectin-3 binding peptide with Kd of 88 nM and shows anticancer activity.